Cirrhosis of the liver in long-term marrow transplant survivors

Blood

Volumn 93, Issue 10, 1999, Pages 3259-3266

  Strasser, Simone I ^a   Sullivan, Keith M ^a   Myerson, David ^a   Spurgeon, Catherine L ^a   Storer, Barry ^a   Schoch, H Gary ^a   Murakami, Carol S ^a   McDonald, George B ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0033562639     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.10.3259.410k13_3259_3266     Document Type: Article

References (66)

1. Strasser SI, McDonald GB: Hepatobiliary complications of hematopoietic stem cell transplantation, in Schiff ER, Sorrell MF, Maddrey WC (eds): Schiff's Diseases of the Liver. Philadelphia, PA, Lipincott-Raven, 1999, p 1617
2. Neilson JR, Harrison P, Skidmore SJ, King JA, Collingham KE, Milligan DW: Chronic hepatitis C in long-term survivors of haematological malignancy treated in a single centre. J Clin Pathol 49:230, 1996
3. Ljungman P, Johansson N, Aschan J, Glaumann H, Lonnqvist B, Ringden O, Sparrelid E, Sonnerborg A, Winiarski J, Gahrton G: Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 86:1614, 1995
4. Arico M, Maggiore G, Silini E, Bono F, Vigano C, Cerino A, Mondelli MU: Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 84:2919, 1994
5. Fujii Y, Kaku K, Tanaka M, Kaneko T, Matumoto N, Shinohara K: Hepatitis C virus and liver disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 13:523, 1994
6. Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG, Kim S, Flowers MED, McDonald GB: Hepatitis C virus infection after bone marrow transplantation: A cohort study with 10 year follow-up. Hepatology (in press)
7. Tong MJ, El-Farra N, Reikes A, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463, 1995
8. National Institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C. Hepatology 26:S2, 1997
9. Tandon BN, Joshi YK, Sud R, Koshy A, Jain SK, Tandon HD: Follow-up of survivors of epidemic veno-occlusive disease in India. Lancet 1:730, 1984
10. Snover DC, Weisdorf S, Bloomer J, McGlave P, Weisdorf D: Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 9:443, 1989
11. Rosen AA, Iseri O, Fishbein G, Knodell RG: Nodular regenerative hyperplasia: A cause of ascites and hepatomegaly after chemotherapy for leukemia. Am J Gastroenterol 86:86, 1991
12. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267, 1981
13. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone marrow transplantation. N Engl J Med 292:832, 1975
14. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765, 1985
15. Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, Hill R, Longton G, Lum L, Martin P, McGuffin R, Sanders J, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas ED: Marrow transplantation for severe aplastic anemia: Methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68:119, 1986
16. Storb R, Deeg HJ, Whitehead J, Appelbaum FR, Beatty P, Bensinger W, Buckner CD, Clift RA, Doney F, Farewell V: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after bone marrow transplantation for leukemia. N Engl J Med 314:729, 1986
17. Clift RA, Buckner CD, Appelbaum FR, Bearman SI, Peterson FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill R, McDonald GB, Martin PJ, Sanders JE, Singer J, Stewart P, Sullivan KM, Witherspoon RP, Storb R, Hansen J, Thomas ED: Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission. A randomized trial of two irradiation regimens. Blood 76:1867, 1990
18. Clift RA, Buckner CD, Appelbaum FR, Bryant E, Bearman SI, Peterson FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill R, McDonald GB, Martin P, Meyers JD, Sanders JE, Singer JW, Stewart P, Sullivan KM, Witherspoon RP, Storb R, Hansen JA, Thomas ED: Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens. Blood 77:1660, 1991
19. Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden RA, Bryant E, Deeg HJ, Doney KC, Fisher LD, Hansen JA, Martin P, McDonald GB, Sanders JE, Schoch G, Singer J, Storb R, Sullivan KM, Witherspoon RP, Appelbaum FR: Marrow transplantation for chronic myeloid leukemia. A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84:2036, 1994
20. Sullivan KM, Siadak MF: Stem cell transplantation, in Johnson FE, Virgo KS (eds): Cancer Patient Follow Up. St Louis, MO, Mosby, 1997, p 490
21. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH: The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 31:395, 1978
22. McDonald GB, Hinds MS, Fisher LB, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA: Venocclusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 118:255, 1993
23. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295, 1974
24. Ringden O, Deeg HJ: Clinical spectrum of graft-versus-host disease, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft-vs.-Host Disease. New York, NY, Dekker, 1997, p 525
25. Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB: A coded histologic study of hepatic graft-versus-host disease after human marrow transplantation. Hepatology 8:463, 1988
26. Doney KC, Weiden PL, Storb R, Thomas ED: Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 11:1, 1981
27. Deeg HJ, Loughran TP Jr, Storb R, Kennedy MS, Sullivan KM, Doney K, Appelbaum FR, Thomas ED: Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 40:162, 1985
28. Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, Deeg HJ, Sanders JE, Doney KC, Appelbaum FR, McGuffin R, McDonald GB, Meyers JD, Schubert MM, Gauvreau J, Shulman HM, Sale GE, Anasetti C, Loughran TP, Strom S, Nims J, Thomas ED: Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 72:546, 1988
29. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE, Sullivan KM, Storb R, Thomas ED, Witherspoon RP, Lomen P, Hannigan J, Hansen JA: A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 76:1464, 1990
30. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB, Storb R, Hansen JA: A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment. Blood 77: 1821, 1991
31. Shuhart MC, Myerson D, Childs B, Fingeroth JD, Perry JJ, Snyder DS, Spurgeon CL, Bevan CA, McDonald GB: Marrow transplantation from hepatitis C virus seropositive donors: Transmission rate and clinical course. Blood 84:3229, 1994
32. Kiem HP, McDonald GB, Myerson D, Spurgeon CL, Deeg HJ, Sanders JE, Doney K, Appelbaum F, Sullivan KM, Witherspoon RP, Storb R: Marrow transplantation for hepatitis-associated aplastic anemia: A follow-up of long-term survivors. Biol Blood Marrow Transplant 2:93, 1996
33. Strasser SI, Kowdley KV, Sale GE, McDonald GB: Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 22:167, 1998
34. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671, 1990
35. Koretz RL, Abbey H, Coleman E, Gitnick G: Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med 119:110, 1993
36. Cesaro S, Petris MG, Rossetti R, Cusinato R, Pipan C, Guido M, Masiero L, Botta GA, Meloni GA, Zanesco L: Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90:1315, 1997
37. Locasciulli A, Testa M, Pontisso P, Benvegnu L, Fraschini D, Corbetta A, Noventa F, Masera G, Alberti A: Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90:4628, 1997
38. Vento S, Cainelli F, Mirandola F, Cosco L, Di Perri G, Solbiati M, Ferraro T, Concia E: Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 347:92, 1996
39. Kanamori H, Fukawa H, Maruta A, Harano H, Kodama F, Matsuzaki M, Miyashita H, Motomura S, Okubo T, Yoshiba M, Sekiyama K: Case report: Fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. Am J Med Sci 303:109, 1992
40. Shuhart MC, Myerson D, Spurgeon CL, Bevan CA, Sayers MH, McDonald GB: Hepatitis C virus infection in bone marrow transplant patients after transfusions from anti-HCV positive donors. Bone Marrow Transplant 17:601, 1996
41. Akiyama H, Yoshinaga H, Tanaka T, Hiruma K, Tanikawa S, Sakamaki H, Onozawa Y, Wakita T, Kohara M: Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplant 20:993, 1997
42. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB: Venocclusive disease of the liver after marrow transplantation: Histologic correlates of clinical signs and symptoms. Hepatology 19:1171, 1994
43. Rio B, Bauduer F, Arrago JP, Zittoun R: N-terminal peptide of type III procollagen: A marker for the development of hepatic venoocclusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplant 11:471, 1993
44. Heikinheimo M, Halila R, Fasth A: Serum procollagen type III is an early and sensitive marker for venocclusive disease of the liver in children undergoing bone marrow transplantation. Blood 83:3036, 1994
45. Schuppan D, Farrand A, Oesterling C, Gehrmann M, McDonald GB: Circulating markers of hepatic fibrosis predict evolution of venocclusive disease after marrow transplantation. Hepatology 26: 452A, 1997 (abstr)
46. Fried MW, Duncan A, Soroka S, Connaghan DG, Farrand A, Strauss RM, Boyer TD, McDonald GB: Serial measurement of serum hyaluronic acid in veno-occlusive disease (VOD) following bone marrow transplantation (BMT): Correlation with severity. Hepatology 26:149A, 1997 (abstr)
47. Watanabe K, Iwaki H, Satoh M, Ikeda T, Ichimiya S, Suzuki N, Kudoh T, Oda T, Matsuura A, Mori M, Kikuchi K: Veno-occlusive disease of the liver following bone marrow transplantation: A clinical-pathological study of autopsy cases. Artif Organs 20:1145, 1996
48. Friedman SL: Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 32:424, 1997
49. Stal P: Iron as a hepatotoxin. Dig Dis 13:205, 1995
50. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB: Iron in liver diseases other than hemochromatosis. Semin Liver Dis 16:65, 1996
51. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 6:24, 1986
52. Risdon RA, Barry M, Flynn DM: Transfusional iron overload: The relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 116:83, 1975
53. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825, 1997
54. Bjorkander J, Cunningham-Rundles C, Lundin P, Olsson R, Soderstrom R, Hanson LA: Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 84:107, 1988
55. Bjoro K, Froland SS, Yun Z, Samdal H, Haaland T: Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 331:1607, 1994
56. Lumbreras C, Colina F, Loinaz C, Domingo MJ, Fuertes A, Dominguez P, Gomez R, Aguado JM, Lizasoain M, Gonzalez-Pinto I, Garcia I, Moreno E, Noriega AR: Clinical, virological, and histologic evolution of hepatitis C virus infection in liver transplant recipients. Clin Infect Dis 26:48, 1998
57. Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL Jr: Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 26:1646, 1997
58. Vierling JM, Villamil FG, Rojter SE, Camacho KB, Goldman DE: Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation. J Viral Hepatol 4:117, 1997 (suppl 1)
59. Makris M, Preston FE, Rosendaal FR, Underwood JC, Rice KM, Triger DR: The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 94:746, 1996
60. Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, Rey C, Abad MA, Rodriguez M, Sales Gilabert M, Gonzalez F, Miron P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E: Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26:1, 1997
61. Knapp AB, Crawford JM, Rappeport JM, Gollan JL: Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 92:513, 1987
62. Stechschulte DJ Jr, Fishback JL, Emami A, Bhatai P: Secondary biliary cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 98:223, 1990
63. Myerson D, Spurgeon CL, Foster S, McDonald GB: Prevalence of HCV infection among patients with hematologic disorders, 1987-1995: Effect of blood donor testing for anti-HCV by 2nd generation ELISA. Hepatology 22:961A, 1995 (abstr)
64. Wingard JR, Curbow B, Baker F, Piantadosi S: Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med 114:113, 1991
65. Bush NE, Haberman M, Donaldson G, Sullivan KM: Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 40:479, 1995
66. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr: Solid cancers after bone marrow transplantation. N Engl J Med 336:897, 1997